Innovative Leukemia and Lymphoma Therapy
Written by international experts in the field, this new guide examines cutting-edge clinical studies that investigate innovative therapies and related topics for leukemia and lymphoma.
Innovative Leukemia and Lymphoma Therapy is the only comprehensive and up-to-date overview of the exciting new treatment modalities in leukemia and lymphoma in practice today.
- Leukemia and lymphoma including: tyrosine kinase inhibitors, histon deacetylase inhibitors, and farnesyl transferase inhibitors
- Radioimmunotherapy, gene-directed therapy, and immunotherapy by vaccination
- Monoclonal antibodies
- Anti-angiogenesis approaches
- The concerns of conventional but novel anticancer agents
- Modulation of classical multidrug resistancemodulators of single agent drug resistance
Title: Innovative Leukemia and Lymphoma Therapy
Author: Gertjian J. L. Kaspers; Bertrand Coiffier; Michael C. Heinrich; Elihu H. Estey
Rules and Guidance for Pharmaceutical Manufacturers and Distributors (Orange Guide) 2015 2015 US$ 98.50 673 pages
Reengineering Health Care 2010 US$ 26.99 241 pages